An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder

An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder

Objective: To assess efficacy and safety of mirabegron 25 mg/day and 50 mg/day for overactive bladder in Chinese participants. Methods: Participants of ≥18 years with overactive bladder symptoms lasting for ≥12 weeks, a mean of ≥8 micturitions per 24 h, and a mean of at least one episode of Grade 3...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhipeng Zhang, Deyi Luo, Zhong Chen, Peng Zhang, Ganping Zhong, Keji Xie, Zhuoqun Xu, Xudong Li, Jianye Wang, Yingfan Yang, Farid Abdul Hadi, Arianne Schild
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Asian Journal of Urology
Subjects:
β3-adrenoceptor agonist
Chinese population
Micturition
Mirabegron
Overactive bladder
Online Access:http://www.sciencedirect.com/science/article/pii/S2214388224000936
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2214388224000936

Similar Items